Foley Attorneys Named to 2022 Wisconsin Super Lawyers and Rising Stars Lists
15 November 2022
Foley & Lardner LLP is pleased to announce that 16 of its attorneys were selected for inclusion in the 2022 Wisconsin Super Lawyers and Rising Stars lists.
Super Lawyers is a rating service of outstanding lawyers from more than 70 practice areas who have attained a high degree of peer recognition and professional achievement. The patented selection process includes independent research, peer nominations, and peer evaluations. Each year, only 5 percent of attorneys in the state are selected to the Super Lawyers list.
2022 Wisconsin Super Lawyers
Madison
- Daniel Kaplan, Employment & Labor
- Naikang Tsao, IP Litigation
Milwaukee
- Linda Benfield, Environmental
- James Clark, Business Litigation
- Michael Hatch, Real Estate
- James McKeown, Antitrust Litigation
- Thomas Shriner Jr., General Litigation
2022 Wisconsin Rising Stars
Madison
- Eric Hatchell, Business Litigation
- Jennifer Luther, Civil Litigation: Defense
- Samuel Robertson, Estate & Probate
Milwaukee
- Gregory Heinen, Business Litigation
- William Hughes, Estate & Probate
- Jessica Lothman, Government Finance
- Andrew Meerkins, Business Litigation
- Joshua Roling, Real Estate
- Morgan Tilleman, Mergers & Acquisitions
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”